Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Hologic, Inc.    HOLX

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Hologic, Inc. : Hologic to Present at Three Upcoming Investor Conferences

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/09/2013 | 01:05pm CET

BEDFORD, Mass., May 9, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced that company management will participate in the following investor conferences:

    --  Glenn Muir, Executive Vice President and Chief Financial Officer, will
        present at:
        --  The Bank of America Merrill Lynch 2013 Health Care Conference in Las
            Vegas, Nevada on Tuesday, May 14, 2013 at 11:40 a.m. Eastern Time
            (ET).
        --  The William Blair 33(rd) Annual Growth Stock Conference in Chicago,
            Illinois on Wednesday, June 12, 2013 at 1:40 p.m. ET.
    --  Rob Cascella, President and Chief Executive Officer, will present at:
        --  The Goldman Sachs 34(th) Annual Global Healthcare Conference in
            Rancho Palos Verdes, California on Wednesday, June 12, 2013 at 2:20
            p.m. ET.

Interested parties are invited to listen to the live audio webcasts of the investor presentations on the investor section of Hologic's website at www.hologic.com/investors-overview. Archives of the presentations will be available for replay following the conferences.

About Hologic, Inc.:

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women. The Company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts. For more information, visit www.hologic.com.


    Contacts:


    Deborah R. Gordon                  Al Kildani

    Vice President, Investor Relations Senior Director, Investor Relations

    (781) 999-7716                     (858) 410-8653

    deborah.gordon@hologic.com         al.kildani@hologic.com

SOURCE Hologic, Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on HOLOGIC, INC.
01/12 HOLOGIC : FDA Grants PMA Approval for Hologic's Aptima® HIV-1 Quant Assay
01/10 GRIFOLS : to Acquire Hologic Blood Donor Screening Unit
01/05 HOLOGIC : to Announce Financial Results for the First Quarter of Fiscal 2017 on ..
01/04 HOLOGIC : Appoints President of EMEA and Canada, Completing International Leader..
01/03 HOLOGIC : FDA Grants PMA Approval for Hologic's Aptima® HIV-1 Quant Assay
2016 HOLOGIC : to Present at the 35th Annual J.P. Morgan Healthcare Conference
2016 HOLOGIC : Combine Solicitation - Hologic DXA Service
2016 HOLOGIC, INC. (NASDAQ : HOLX) Files An 8-K Departure of Directors or Certain Off..
2016 GRIFOLS : Hologic sells blood-screening business to Grifols for $1.85 million
2016 HOLOGIC INC : Change in Directors or Principal Officers, Financial Statements an..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
01/19 Davos CEOs 'go local' on supply chain in Trump era
01/08DJCorrection to Parkinson's Therapy Story
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
01/18 Premarket analyst action - healthcare
01/04 Today's analyst action
01/04 Premarket analyst action
01/03 FDA OKs Hologic's Aptima HIV-1 Quant assay
01/02 Healthcare option investors are missing out on preannouncement potential - GS